Cargando…

Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature

Psoriasis is a relatively common immune-mediated chronic inflammatory skin disease. It is well known that interferon-beta, a drug used in the management of relapsing-remitting multiple sclerosis, could exacerbate or induce de novo psoriasis. There is limited evidence in the literature based only on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambrianides, Sakis, Kinnis, Evgenios, Leonidou, Eleni, Pantzaris, Marios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180259/ https://www.ncbi.nlm.nih.gov/pubmed/30323758 http://dx.doi.org/10.1159/000492891

Ejemplares similares

Prevalence of Anti-JC Virus (JCV) Antibodies in the Multiple Sclerosis (MS) Population in Cyprus: A Retrospective Study
por: Lambrianides, Sakis, et al.
Publicado: (2019)

Natalizumab-Induced Pustular Psoriasis of Palms and Soles
por: Ozarslan, Bengisu, et al.
Publicado: (2022)

SARS CoV- 2 vaccination induces antibodies against cardiolipin
por: Krashias, George, et al.
Publicado: (2022)

The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients
por: Deeba, Elie, et al.
Publicado: (2020)

Serum Reactive Antibodies against the N-Methyl-D-Aspartate Receptor NR2 Subunit—Could They Act as Potential Biomarkers?
por: Hadjiagapiou, Maria S., et al.
Publicado: (2023)

Telmisartan aggravates pustular psoriasis
por: Keerthi, Subramaniam, et al.
Publicado: (2015)

A Preclinical Investigation on the Role of IgG Antibodies against Coagulant Components in Multiple Sclerosis
por: Hadjiagapiou, Maria S., et al.
Publicado: (2023)

SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments
por: Lambrianides, Anastasia, et al.
Publicado: (2023)

Improvement of Comorbid Psoriasis in Patients With MS Treated With Natalizumab
por: Berkovich, Regina, et al.
Publicado: (2021)

Docetaxel-Aggravated Psoriasis
por: Yang, Seungkeol, et al.
Publicado: (2019)

A Case of Drug-Induced Liver Injury Secondary to Natalizumab
por: Santoiemma, Phillip P., et al.
Publicado: (2020)

Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review
por: Yasuda, Yuichiro, et al.
Publicado: (2019)

Natalizumab-induced pneumonitis
por: Kaninia, Stefania, et al.
Publicado: (2021)

Natalizumab: COVID-19 infection: case report
Publicado: (2021)

Natalizumab: Progressive multifocal leukoencephalopathy: case report
Publicado: (2021)

Genetic Markers for Thrombophilia and Cardiovascular Disease Associated with Multiple Sclerosis
por: Hadjiagapiou, Maria S., et al.
Publicado: (2022)

Natalizumab-induced thrombocytopenia: A case report
por: Azimi, Amirreza, et al.
Publicado: (2022)

Natalizumab: Pneumonia caused by COVID-19: case report
Publicado: (2020)

Natalizumab: COVID-19 infection: 19 case reports
Publicado: (2022)

Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
Publicado: (2022)

Primary sternal osteomyelitis in a 40 days old infant: a case report and review of the literature
por: Pettas, Nikolaos S, et al.
Publicado: (2009)

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
por: Pafiti, Anna, et al.
Publicado: (2023)

Pulmonary eosinophilia associated to treatment with natalizumab
por: Curto, Elena, et al.
Publicado: (2016)

Localized psoriasis herpeticum: Case report and review of literature
por: George, Mamatha, et al.
Publicado: (2011)

Psoriasis of the Lips: A Case Report with Review of the Literature
por: Chakiri, Radia
Publicado: (2021)

Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy
por: Lo Buono, Viviana, et al.
Publicado: (2022)

Natalizumab: Coronavirus disease-2019 infection: 6 case reports
Publicado: (2022)

Alemtuzumab/natalizumab/ocrelizumab: COVID-19: 3 case reports
Publicado: (2021)

A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine
por: Ardeshna, Kenit P, et al.
Publicado: (2017)

Arteriovenous malformation in cheek and tongue aggravated by cellulitis: A case report and literature review
por: Kaouani, Amine, et al.
Publicado: (2021)

Acute retinal necrosis caused by co-infection with multiple viruses in a natalizumab-treated patient: a case report and brief review of literature
por: Cheraqpour, Kasra, et al.
Publicado: (2021)

Does molecular scarring in psoriasis exist? A review of the literature
por: Kasprowicz-Furmańczyk, Marta, et al.
Publicado: (2023)

Fatal COVID-19 in an MS patient on natalizumab: A case report
por: Rimmer, Kathryn, et al.
Publicado: (2020)

Interferon-beta-1a/natalizumab: Lack of efficacy: case report
Publicado: (2021)

Alemtuzumab/cladribine/natalizumab: Lymphopenia and COVID-19 infection: case report
Publicado: (2021)

Isolated Jejunal Perforation Following Bicycle Handlebar Injury in Adults: A Case Report
por: Neofytou, Kyriakos, et al.
Publicado: (2013)

Immune Reconstitution Inflammatory Syndrome Mimicking Progressive Multifocal Leucoencephalopathy in a Multiple Sclerosis Patient Treated With Natalizumab: A Case Report and Review of the Literature
por: Evangelopoulos, Maria-Eleptheria, et al.
Publicado: (2015)

A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide
por: Mumoli, Laura, et al.
Publicado: (2013)

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
por: Pinter, Andreas, et al.
Publicado: (2019)

Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report
por: Sotgiu, Stefano, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_be3o000s7hdpnuatbo073uolkm